154 related articles for article (PubMed ID: 10996100)
1. Clinical spectrum of Raynaud's phenomenon in patients referred to vascular clinic.
Knapik-Kordecka M; Wysokinski WE
Cardiovasc Surg; 2000 Oct; 8(6):457-62. PubMed ID: 10996100
[TBL] [Abstract][Full Text] [Related]
2. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
[TBL] [Abstract][Full Text] [Related]
3. [Raynaud's phenomenon - first sign of malignancy: case report].
Sutić A; Gračanin G; Morović-Vergles J
Acta Med Croatica; 2014 Jun; 68(3):295-8. PubMed ID: 26016221
[TBL] [Abstract][Full Text] [Related]
4. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of clinical signs and symptoms in patients with Raynaud's phenomenon. A cross-sectional study.
Wollersheim H; Thien T
Neth J Med; 1990 Dec; 37(5-6):171-82. PubMed ID: 2074908
[TBL] [Abstract][Full Text] [Related]
6. [Raynaud's phenomena: diagnostic and treatment study].
Priollet P
Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
[TBL] [Abstract][Full Text] [Related]
7. Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: an entity independent of scleroderma?
Sachsenberg-Studer EM; Prins C; Saurat JH; Salomon D
J Am Acad Dermatol; 2000 Oct; 43(4):631-4. PubMed ID: 11004618
[TBL] [Abstract][Full Text] [Related]
8. Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?
Caccavo D; Del Porto F; Garzia P; Mitterhofer AP; Galluzzo S; Rigon A; Vadacca M; Navajas MF; Amoroso A; Afeltra A
Ann Rheum Dis; 2003 Oct; 62(10):1003-5. PubMed ID: 12972482
[TBL] [Abstract][Full Text] [Related]
9. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
10. How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases.
Priollet P; Vayssairat M; Housset E
Am J Med; 1987 Sep; 83(3):494-8. PubMed ID: 3661586
[TBL] [Abstract][Full Text] [Related]
11. Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients.
Planchon B; Pistorius MA; Beurrier P; De Faucal P
Angiology; 1994 Aug; 45(8):677-86. PubMed ID: 8048777
[TBL] [Abstract][Full Text] [Related]
12. Nailfold capillaroscopy in the screening and diagnosis of Raynaud's phenomenon.
Mannarino E; Pasqualini L; Fedeli F; Scricciolo V; Innocente S
Angiology; 1994 Jan; 45(1):37-42. PubMed ID: 8285382
[TBL] [Abstract][Full Text] [Related]
13. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.
DiGiacomo RA; Kremer JM; Shah DM
Am J Med; 1989 Feb; 86(2):158-64. PubMed ID: 2536517
[TBL] [Abstract][Full Text] [Related]
14. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
Serri J; Legré R; Veit V; Guardia C; Gay AM
Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
[TBL] [Abstract][Full Text] [Related]
15. [Validity of plethysmography and the digital temperature recovery test in the diagnosis of primary and occupational Raynaud's phenomenon].
Laroche GP; Thériault G
Clin Invest Med; 1987 Mar; 10(2):96-102. PubMed ID: 3581549
[TBL] [Abstract][Full Text] [Related]
16. Raynaud's syndrome: diagnosis and treatment.
Whitaker L; Kelleher A
J Vasc Nurs; 1994 Mar; 12(1):10-3. PubMed ID: 7748770
[TBL] [Abstract][Full Text] [Related]
17. [Raynaud's phenomenon, disease or syndrome?].
Fiessinger JN
Rev Prat; 2011 Sep; 61(7):899-903. PubMed ID: 22039719
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the patient with Raynaud's phenomenon.
Coffman JD
Postgrad Med; 1985 Aug; 78(2):175-7, 180-3. PubMed ID: 4022848
[TBL] [Abstract][Full Text] [Related]
19. Office evaluation and treatment of Raynaud's phenomenon.
Bolster MB; Maricq HR; Leff RL
Cleve Clin J Med; 1995; 62(1):51-61. PubMed ID: 7859402
[TBL] [Abstract][Full Text] [Related]
20. Raynaud's disease: pathophysiology, diagnosis, and treatment.
Hodges H
J Am Acad Nurse Pract; 1995 Apr; 7(4):159-64. PubMed ID: 7756043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
